Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 4
1959 1
1961 1
1962 2
1964 2
1971 2
1974 1
1975 1
1979 1
1982 1
1984 1
1985 1
1986 4
1987 1
1988 1
1989 2
1990 6
1991 1
1992 4
1993 1
1994 7
1995 3
1996 3
1997 4
1998 10
1999 12
2000 11
2001 14
2002 21
2003 20
2004 36
2005 51
2006 48
2007 62
2008 77
2009 94
2010 108
2011 116
2012 141
2013 157
2014 160
2015 166
2016 166
2017 178
2018 194
2019 214
2020 228
2021 297
2022 178
Text availability
Article attribute
Article type
Publication date

Search Results

2,508 results
Results by year
Filters applied: . Clear all
Page 1
Plant "helper" immune receptors are Ca2+-permeable nonselective cation channels.
Jacob P, Kim NH, Wu F, El-Kasmi F, Chi Y, Walton WG, Furzer OJ, Lietzan AD, Sunil S, Kempthorn K, Redinbo MR, Pei ZM, Wan L, Dangl JL. Jacob P, et al. Among authors: chi y. Science. 2021 Jul 23;373(6553):420-425. doi: 10.1126/science.abg7917. Epub 2021 Jun 17. Science. 2021. PMID: 34140391 Free PMC article.
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.
Xu J, Shen L, Zhou Z, Li J, Bai C, Chi Y, Li Z, Xu N, Li E, Liu T, Bai Y, Yuan Y, Li X, Wang X, Chen J, Ying J, Yu X, Qin S, Yuan X, Zhang T, Deng Y, Xiu D, Cheng Y, Tao M, Jia R, Wang W, Li J, Fan S, Peng M, Su W. Xu J, et al. Among authors: chi y. Lancet Oncol. 2020 Nov;21(11):1500-1512. doi: 10.1016/S1470-2045(20)30496-4. Epub 2020 Sep 20. Lancet Oncol. 2020. PMID: 32966811 Clinical Trial.
Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images.
Zhang K, Liu X, Xu J, Yuan J, Cai W, Chen T, Wang K, Gao Y, Nie S, Xu X, Qin X, Su Y, Xu W, Olvera A, Xue K, Li Z, Zhang M, Zeng X, Zhang CL, Li O, Zhang EE, Zhu J, Xu Y, Kermany D, Zhou K, Pan Y, Li S, Lai IF, Chi Y, Wang C, Pei M, Zang G, Zhang Q, Lau J, Lam D, Zou X, Wumaier A, Wang J, Shen Y, Hou FF, Zhang P, Xu T, Zhou Y, Wang G. Zhang K, et al. Among authors: chi y. Nat Biomed Eng. 2021 Jun;5(6):533-545. doi: 10.1038/s41551-021-00745-6. Epub 2021 Jun 15. Nat Biomed Eng. 2021. PMID: 34131321
A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
Wang H, Ding Y, Chen Y, Jiang J, Chen Y, Lu J, Kong M, Mo F, Huang Y, Zhao W, Fang P, Chen X, Teng X, Xu N, Lu Y, Yu X, Li Z, Zhang J, Wang H, Bao X, Zhou D, Chi Y, Zhou T, Zhou Z, Chen S, Teng L. Wang H, et al. Among authors: chi y. Gastric Cancer. 2021 Nov;24(6):1227-1241. doi: 10.1007/s10120-021-01201-9. Epub 2021 Jun 6. Gastric Cancer. 2021. PMID: 34095982 Free PMC article.
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Li H, Sisoudiya SD, Martin-Giacalone BA, Khayat MM, Dugan-Perez S, Marquez-Do DA, Scheurer ME, Muzny D, Boerwinkle E, Gibbs RA, Chi YY, Barkauskas DA, Lo T, Hall D, Stewart DR, Schiffman JD, Skapek SX, Hawkins DS, Plon SE, Sabo A, Lupo PJ. Li H, et al. Among authors: chi yy. J Natl Cancer Inst. 2021 Jul 1;113(7):875-883. doi: 10.1093/jnci/djaa204. J Natl Cancer Inst. 2021. PMID: 33372952 Free PMC article.
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study.
Xu J, Shen L, Bai C, Wang W, Li J, Yu X, Li Z, Li E, Yuan X, Chi Y, Yin Y, Lou W, Xu N, Bai Y, Zhang T, Xiu D, Wang X, Yuan Y, Chen J, Qin S, Jia R, Lu M, Cheng Y, Zhou Z, Li J, He J, Su W. Xu J, et al. Among authors: chi y. Lancet Oncol. 2020 Nov;21(11):1489-1499. doi: 10.1016/S1470-2045(20)30493-9. Epub 2020 Sep 20. Lancet Oncol. 2020. PMID: 32966810 Clinical Trial.
2,508 results